In accordance
with the terms of 5 CFR 1320, OMB approves this ICR for a period of
three years. If FDA requests an extension of this approval,FDA
should make significant progress in making an electronic submission
available. If electronic submission is not available, the agency
should submit a timeline for implementation and report on
progress.
Inventory as of this Action
Requested
Previously Approved
03/31/2015
36 Months From Approved
114
0
0
1,368
0
0
0
0
0
This ICR collects information
necessary for FDA to make a determination about the classification
of devices intended for human use. Section 513 of the Federal Food,
Drug, and Cosmetic Act (FD&C Act or the act) (21 U.S.C. 360c,
et seq.) provides that devices classified by the regulatory
controls needed to provide reasonable assurance of their safety and
effectiveness. Within 60 days of the receipt of a written request
for information respecting the class into which a device falls or
the requirements applicable, the Secretary of Health and Human
Services must provide a written statement of the classification.
FDA's Center for Devices and Radiological Health (CDRH) and Center
for Biologics Evaluation and Research (CBER) will use the
information submitted in this ICR to provide that
information.
US Code:
21
USC 360c Name of Law: Federal Food, Drug, and Cosmetic Act
FDA is now issuing a guidance
entitled "FDA and Industry Procedures for section 513(g) Requests
for Information under the Federal Food, Drug, and Cosmetic Act" to
assist individuals in preparing the supplemental information
necessary to process the requests for a new medical device
classification. FDA's Center for Devices and Radiological Health
(CDRH) and Center for Biologics Evaluation and Research (CBER) will
use the information submitted in a 513(g) request to provide
information regarding classification information and/or regulator
requirements for a single product. Parties seeking information for
multiple products must submit separate 513(g) requests for each
product.
$176,472
No
No
No
No
No
Uncollected
Daniel Gitteson 3017965156
daniel.gitteson@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.